External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2 gliomas: NCOG study 6H-82-2

International Journal of Radiation Oncology, Biology, Physics

Volumn 21, Issue 3, 1991, Pages 601-606

  Gutin, Philip H ^a   Prados, Michael D ^a   Phillips, Theodore L ^a   Wara, William M ^a   Larson, David A ^a   Leibel, Steven A ^a   Sneed, Penny K ^a   Levin, Victor A ^a   Weaver, Keith A ^a   Silver, Pamela ^a   Lamborn, Kathleen ^b   Lamb, Sharon ^a   Ham, Brigid ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Radiation Oncology School of Medicine University of California ^*  (United States)

Author keywords

Glioblastoma multiforme; Interstitial brachytherapy; Iodine 125; Malignant glioma; Stereotaxy

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BRAIN TUMOR; CANCER RADIOTHERAPY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIOTOMY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; IODINE RADIOISOTOPES; LOMUSTINE; MALE; MIDDLE AGE; PROCARBAZINE; RETROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.; VINCRISTINE;

EID: 0026072845     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(91)90676-U     Document Type: Article

References (27)

1. Interstitial irradiation of brain tumors: a review
2. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme
3. Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas
4. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma
5. Corticosteroid therapy in patients with cerebral tumors: Benefits, mechanisms, problems, practicalities
6. A coaxial catheter system for afterloading radioactive sources for the interstitial irradiation of brain tumors
7. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources
8. Polyamine accumulation and vasogenic edema in the genesis of late delayed radiation injury of the nervous system
9. Brachytherapy of recurrent malignant brain tumors with re movable high-activity iodine-125 sources
10. Reoperation for recurrent glioblastoma and anaplastic astrocytoma
11. Preliminary experience with the Brown-Roberts-Wells (BRW) computerized tomographic stereotaxic guidance system
12. Assumptions in the radiotherapy of glioblastoma
13. Nonparametric estimation from incomplete observations
14. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas
15. Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors
16. Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
17. Initial analysis of NCOG 6G82-1: bromodeoxyuridine (BUdR) during irradiation followed by CCNU, procarbazine, and vincristine (PCV) chemotherapy for malignant gliomas
18. Evaluation of survival data and two new rank order statistics arising in its consideration
19. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001
20. Interstitial irradiation and hyperthermia for the treatment of recurrent malignant brain tumors
21. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas
22. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
23. A CT-based computerized treatment planning system for I-125 stereotactic brain implants
24. Corticosteroid toxicity in neuro-oncology patients
25. Reoperation for glioblastoma